On May 23, 2018, we published revised versions of our Privacy Policy and User Agreements. Please read these updated terms and take some time to understand them. Your use of our services is subject to these revised terms.
Yes, I Agree.

Pure Extract Technologies Inc. Set to Become Dominant Extraction Company in Growing Mushroom Space

  • Functional mushrooms seeing rise in popularity due to health benefits, alternative medicine options
  • Predictions show global medicinal mushroom market growing annually by $13.88 billion
  • Pure Extracts is ideally positioned to enter the space as experienced producer

Used for centuries for their impressive medicinal properties and health benefits, functional mushrooms are enjoying a rise in popularity, due at least in part to increased research and study of the natural fungi as well as trends toward alternative natural health options. Pure Extract Technologies, a private, plant-based extraction company with a new vertical in functional mushrooms, is focused on becoming the dominant extraction company in the industry and a leader in the rapid development and commercialization of functional mushroom products.

In an article titled “Here’s What You Need to Know About Functional Mushroom,” Stephanie Ferrari, a Massachusetts-based registered dietitian, says that there is deep scientific literature that points to the healing properties of mushrooms, specifically their immune system and cancer-prevention benefits (http://cnw.fm/H8a3L). “Research suggests that mushrooms not only strengthen our immune systems but may also be useful in treating certain diseases like asthma, allergies and arthritis due to their anti-inflammatory properties,” she says.

Beyond that, the article notes that “mushrooms are low in calories, high in protein, and good sources of B vitamins, minerals and fiber. . . . Several are considered adaptogens, which means they help us to cope with stress.”

In addition, research published in “Integrative Medicine: A Clinician’s Journal,” notes that, for certain types of mushrooms, “an abundance of in vitro evidence exists that elucidates the anticancer immunological mechanisms. Preliminary research in humans is also available and is promising for treatment” (http://cnw.fm/yKf42).

The functional mushroom industry is among the fastest growing in North America, with forecasts predicting the global medicinal mushroom market will grow annually by $13.88 billion (http://cnw.fm/RH2vZ). As the industry transitions from dry biomass to extracts, many companies are unprepared for this new opportunity.

Pure Extracts, on the other hand, is ideally positioned to enter the space as an experienced producer. With a team of qualified experts and cutting-edge extraction technology, the company is set up for long-term strategic distribution and product innovation. Located in Pemberton, British Columbia, the company’s facility is built for EU-GMP certification, which allows for international sales and ensures the production of high-quality, high-purity formulations on a commercial scale.

Further establishing its power in the market, Pure Extracts has signed nondisclosure agreements to explore joint-development endeavors for product launches slated for potential Q4 delivery. The company also inked an advisory agreement with Dr. Alexander MacGregor, founder of Transpharm Canada Inc., the parent company of Toronto Institute of Pharmaceutical Technology, whose facility is a fully compliant Health Canada-licensed, Good Manufacturing Practice manufacturing and testing facility and is a full-service, clinical-development business that provides clinical trial services to biotechnology companies.

For more information, visit the company’s website at www.PureExtractsCorp.com.

NOTE TO INVESTORS: The latest news and updates relating to Pure Extracts are available in the company’s newsroom at http://cnw.fm/Pure

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

Archives

Select A Month

Official NewsWire Relationships

Benzinga Cannabis Capital Conference Cannabis Business Summit & Expo 2019 Cannabis Drinks Expo Cannabis World Congress & Business Exposition MjMicro Conference New England Cannabis Network O'Cannabiz Conference & Expo USA CBD Expo

CannabisNewsWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 303.498.7722